Atezolizumab/bevacizumabAcute kidney injury: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2037卷 / 1期

关键词：

D O I：

10.1007/s40278-024-71758-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：65 / 65

相关论文

共 50 条

[1] BevacizumabAcute kidney injury, proteinuria and thrombotic microangiopathy: case report
Reactions Weekly, 2023, 1956 (1) : 101 - 101
[2] BevacizumabAcute pancreatitis: case report
Reactions Weekly, 2022, 1901 (1) : 129 - 129
[3] BevacizumabAcute pancreatitis: case report
Reactions Weekly, 2021, 1886 (1) : 97 - 97
[4] BevacizumabAcute pancreatitis: case report
Reactions Weekly, 2018, 1722 (1) : 74 - 74
[5] BevacizumabAcute pancreatitis: case report
Reactions Weekly, 2020, 1793 (1) : 99 - 99
[6] BevacizumabAcute digestive haemorrhage: case report
Reactions Weekly, 2018, 1726 (1) : 87 - 87
[7] BevacizumabAcute renal failure: case report
Reactions Weekly, 2016, 1595 (1) : 40 - 40
[8] Atezolizumab/pembrolizumabAcute kidney injury: 4 case reports
Reactions Weekly, 2023, 1971 (1) : 50 - 50
[9] Atezolizumab/pembrolizumabDrug-induced liver injury: case report
Reactions Weekly, 2020, 1835 (1) : 55 - 55
[10] Atezolizumab/bevacizumabIntratumoral haemorrhage, hepatitis and liver injury: case report
Reactions Weekly, 2023, 1954 (1) : 91 - 91

← 1 2 3 4 5 →